Background and Objective Atrial fibrillation (AF), the most common cardiac arrhythmia,
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …

Optimizing the anticoagulation therapy is of pivotal importance in patients with a malignant
tumor, as venous thromboembolism (VTE) has become the second-leading cause of death …

Introduction: During the COVID-19 outbreak, non-urgent clinic visits or cardiac interventional
procedures were postponed to a later date, and the implementation of telemedicine has …

Direct oral anticoagulants (DOACs) have been demonstrated to be more effective and safer
than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial …

Measurement of direct oral anticoagulants (DOACs) activity is not routinely necessary.
Indeed, evaluation of DOACs plasmatic concentration is discouraged for the majority of …

Background Octogenarian patients are at high risk of both ischaemic and bleeding events,
and the low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …

Currently, direct oral anticoagulants (DOACs) are the first-line anticoagulant strategy in
patients with non-valvular atrial fibrillation (NVAF). They are characterized by a more …

Background: Elderly patients are at high risk of both ischaemic and bleeding events, and the
low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …

Purpose Older age is associated with inappropriate dose prescription of direct oral
anticoagulants. The aim of our study was to describe the prevalence and the clinical …

Aging is an important risk factor for adverse events in elderly patients with atrial fibrillation
(AF) and complicates the management of anticoagulation. Underuse of oral anticoagulants …